Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension
Pharmacoecon Open
.
2024 Jul;8(4):641.
doi: 10.1007/s41669-024-00485-8.
Authors
Rod S Taylor
1
,
Anthony Bentley
2
,
Kaylie Metcalfe
2
,
Melvin D Lobo
3
,
Ajay J Kirtane
4
,
Michel Azizi
5
6
7
,
Christopher Clark
8
,
Kieran Murphy
9
,
Jennifer H Boer
10
,
Marjolijn van Keep
10
,
An Thu Ta
10
,
Neil C Barman
9
,
Garrett Schwab
9
,
Ron Akehurst
11
12
,
Roland E Schmieder
13
Affiliations
1
MRC/CSO Social and Public Health Sciences Unit and Robertson Centre for Biostatistics, Institute of Health and Well Being, University of Glasgow, 90 Byres Rd, Glasgow, G12 8TB, UK.
[email protected]
.
2
Mtech Access Limited, Bicester, Oxfordshire, UK.
3
Barts NIHR Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London, UK.
4
Columbia University Irving Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA.
5
Université de Paris, Paris, France.
6
Hypertension Department and DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
7
INSERM, CIC1418, Paris, France.
8
Primary Care Research Group, University of Exeter Medical School, Exeter, UK.
9
ReCor Medical, Palo Alto, CA, USA.
10
BresMed Netherlands, Utrecht, The Netherlands.
11
BresMed Health Solutions, Sheffield, UK.
12
University of Sheffield, Sheffield, UK.
13
Nephrology and Hypertension, University Hospital Erlangen, Friedrich Alexander University, Erlangen, Germany.
PMID:
38717555
PMCID:
PMC11252093
DOI:
10.1007/s41669-024-00485-8
No abstract available
Publication types
Published Erratum